Department of Radiology, H. Lee Moffitt Cancer Center, Tampa, Fla.
Department of Radiology, H. Lee Moffitt Cancer Center, Tampa, Fla.
Am J Med. 2018 Apr;131(4):357-364. doi: 10.1016/j.amjmed.2017.12.006. Epub 2017 Dec 21.
Fluorine-18 fluorodeoxyglucose (F-FDG) positron emission tomography (PET) hybrid examinations (PET/computed tomography, PET/magnetic resonance imaging) have become the most common PET imaging tools in the evaluation of the oncologic patient. Therefore it is of paramount importance that physicians who take care of oncology patients in any capacity are familiar with the basics of when these examinations are indicated, know how to best prepare the patients, and understand the benefits and limitations of the procedure. Additionally, it is important to understand which medical conditions and medications need to be controlled to maintain the diagnostic accuracy of these tests. In this article we aim to explain what F-FDG is, how to best prepare our patients, what PET is, and how these examinations are interpreted. Finally, we discuss some of the limitations of these examinations.
氟-18 氟代脱氧葡萄糖(F-FDG)正电子发射断层扫描(PET)混合检查(PET/计算机断层扫描、PET/磁共振成像)已成为肿瘤患者评估中最常用的 PET 成像工具。因此,至关重要的是,无论以何种身份照顾肿瘤患者的医生都应熟悉这些检查的适应症,了解如何最好地准备患者,并了解该程序的益处和局限性。此外,了解哪些医疗条件和药物需要控制以保持这些检查的诊断准确性也很重要。在本文中,我们旨在解释 F-FDG 是什么,如何最好地准备患者,什么是 PET 以及如何解释这些检查。最后,我们讨论了这些检查的一些局限性。